2012-10-06 19:02:59 - Recently published research from Global Markets Direct, "Diabetic Nephropathy - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Diabetic Nephropathy - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Nephropathy. Diabetic Nephropathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468375_diabetic_nephropathy_pipeline_review_ ..


Note*: Certain sections in the report may be removed or altered based on

the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Diabetic Nephropathy.
* A review of the Diabetic Nephropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Diabetic Nephropathy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Diabetic Nephropathy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Diabetic Nephropathy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Nephropathy Overview
Therapeutics Development
An Overview of Pipeline Products for Diabetic Nephropathy
Diabetic Nephropathy Therapeutics under Development by Companies
Diabetic Nephropathy Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Diabetic Nephropathy Therapeutics - Products under Development by Companies
Diabetic Nephropathy Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Diabetic Nephropathy Therapeutics Development
Abbott Laboratories
Sanofi-Aventis
Eli Lilly and Company
Pfizer Inc.
NephroGenex, Inc.
GENTIUM S.p.A.
Dongwha Pharm Co., Ltd.
PhytoHealth Corporation
Proximagen Neuroscience plc.
Angelini Group
IMMD Inc.
DiaKine Therapeutics, Inc.
GenKyoTex S.A.
Indus Biotech Private Limited
Thrasos, Inc.
Concert Pharmaceuticals, Inc.
NOXXON Pharma AG
ChemoCentryx, Inc.
OncoImmune, Inc.
Cebix Incorporated
Ampio Pharmaceuticals, Inc.
Diabetic Nephropathy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
SAR-407899 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PF-03882845 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
THR-123 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NOX-A12 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NOX-E36 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DT-23552 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DW-1029M - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GKT137831 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PF-00489791 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PHN-031 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CCX-140 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
atrasentan hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LY-2382770 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sevelamer carbonate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
bindarit - Drug Profile
Product Description
Mechanism of Action
R&D Progress
danazol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
pioglitazone hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
losartan potassium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GPCR Antagonist - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468375&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.